OTCPK:YBGJ (China)
Â
Ordinary Shares - Class A
$
0.014
-0.00090 (-6.04%)
10:53 AM EST
Business Description
Yubo International Biotech Ltd
NAICS : 334517
SIC : 3841
ISIN : US9883661004
Share Class Description:
YBGJ: Ordinary Shares - Class ATotal Employee Number:
14Description
Yubo International Biotech Ltd is a technology company focused on the research, development, and application of endometrial stem cells. It offers products and services under the brand VIVCELL. Its product offerings include healthcare products for the respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. It also offers stem cell-related services including cell testing and health management consulting services. The company derives its revenue from the sale of certain health management services and the sale of nebulizers containing frozen tubes with medical fluid. The nebulizers are sold directly to consumers on its online e-commerce platform.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | -3.24 | |||||
Debt-to-Equity | -0.02 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -24.65 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year FCF Growth Rate | -6.3 | |||||
3-Year Book Growth Rate | -30.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 96.06 | |||||
9-Day RSI | 89.91 | |||||
14-Day RSI | 84.68 | |||||
3-1 Month Momentum % | -30 | |||||
6-1 Month Momentum % | -43.55 | |||||
12-1 Month Momentum % | -95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.2 | |||||
Quick Ratio | 0.19 | |||||
Days Inventory | 2938.25 | |||||
Days Sales Outstanding | 3960.25 | |||||
Days Payable | 94133.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.5 | |||||
Shareholder Yield % | 13.25 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.67 | |||||
Operating Margin % | -9450 | |||||
Net Margin % | -8675 | |||||
EBITDA Margin % | -8108.33 | |||||
FCF Margin % | -5483.33 | |||||
OCF Margin % | -5483.33 | |||||
ROA % | -110.09 | |||||
ROIC % | -132.38 | |||||
3-Year ROIIC % | -0.97 | |||||
ROC (Joel Greenblatt) % | -500.88 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -2.12 | |||||
EV-to-EBITDA | -2.47 | |||||
EV-to-Revenue | 200.25 | |||||
EV-to-FCF | -3.65 | |||||
Earnings Yield (Greenblatt) % | -47.17 | |||||
FCF Yield % | -27.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:YBGJ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yubo International Biotech Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.012 | ||
| EPS (TTM) ($) | - | ||
| Beta | -0.0627 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 1.14 | ||
| Volatility % | 92.58 | ||
| 14-Day RSI | 84.68 | ||
| 14-Day ATR ($) | 0.000565 | ||
| 20-Day SMA ($) | 0.009127 | ||
| 12-1 Month Momentum % | -95 | ||
| 52-Week Range ($) | 0.0066 - 0.1724 | ||
| Shares Outstanding (Mil) | 170.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Yubo International Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Yubo International Biotech Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 114 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 22 days | ||
| General meeting for 2025 | 2026-07-21 | 0.01 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 0.01 (+0.00%) | ||
| Annual report for 2025 | 2026-03-31 | 0.02 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.01 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-13 | 0.03 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-14 | 0.09 (+0.00%) | ||
| Annual report for 2024 | 2025-03-31 | 0.05 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2024-11-13 | 0.12 (+14.68%) |
Show
Entries
Yubo International Biotech Ltd Frequently Asked Questions
What is Yubo International Biotech Ltd(YBGJ)'s stock price today?
The current price of YBGJ is $0.01. The 52 week high of YBGJ is $0.17 and 52 week low is $0.01.
When is next earnings date of Yubo International Biotech Ltd(YBGJ)?
The next earnings date of Yubo International Biotech Ltd(YBGJ) is 2026-08-13 Est..
Does Yubo International Biotech Ltd(YBGJ) pay dividends? If so, how much?
Yubo International Biotech Ltd(YBGJ) does not pay dividend.
Guru Commentaries on OTCPK:YBGJ
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Yubo International Biotech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers